Immune checkpoints such as programmed death receptor 1 (PD-1), programmed death-ligand 1 (PD-L1) and T-cell immunoglobulin mucin receptor 3 (TIM3) are highly expressed in GBM tissue and correlate with poor outcome2-4. Here, HAVCR2 is linked to glioblastoma.